— Know what they know.
Not Investment Advice

HURA NASDAQ

TuHURA Biosciences, Inc.
1W: -6.8% 1M: -12.7% 3M: +103.5% YTD: +212.2% 1Y: -37.1% 3Y: -19.3% 5Y: -96.3%
$2.50
+0.16 (+6.84%)
 
Weekly Expected Move ±13.3%
$2 $2 $2 $3 $3
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 44 · $159.2M mcap · 35M float · 2.79% daily turnover · Short 62% of daily vol

Balance Sheet Trends

Total Assets
$20M +357.8% ▲
5Y CAGR: +46.7%
Total Liabilities
$5M -9.3% ▼
5Y CAGR: +15.0%
Shareholders Equity
$15M +1036.3% ▲
5Y CAGR: +123.3%
Cash & Investments
$13M +245.3% ▲
5Y CAGR: +39.5%
Total Debt
$203K -91.4% ▼
Net Debt
-$12M -843.5% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$11M$6M$14M$4M$13M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$11M$6M$14M$4M$13M
Net Receivables$0$0$101K$334K$223K
Inventory$0$0$0$0$215K
Other Current Assets$1M$135K$390K$159K$316K
Total Current Assets$12M$6M$15M$4M$20M
Property, Plant & Equip.$150K$617K$419K$203K$323K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$2M$104K$34K$0$34K
Total Non-Current Assets$2M$721K$452K$203K$356K
Total Assets$14M$6M$15M$4M$20M
— Liabilities —
Accounts Payable$2M$414K$2M$2M$3M
Short-Term Debt$0$644K$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$561K$456K$675K$137K$1M
Total Current Liabilities$3M$7M$3M$4M$5M
Long-Term Debt$0$0$0$2M$0
Other Non-Current Liab.$182K$0$0$0$0
Total Non-Current Liabilities$182K$0$21K$2M$43K
Total Liabilities$3M$7M$3M$6M$5M
— Equity —
Common Stock$33K$5K$5K$7K$42K
Retained Earnings-$111M-$49M-$59M-$88M-$111M
Accumulated OCI$21K$0$0$0$0
Total Stockholders Equity$11M-$748K$12M-$2M$15M
Total Liabilities & Equity$14M$6M$15M$4M$20M
— Key Metrics —
Total Debt$0$644K$138K$2M$203K
Net Debt-$11M-$5M-$14M-$1M-$12M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms